Headlines

Samsung Biologics speeds up $1.5 billion fifth plant, CEO reveals at BIO 2023

Samsung Biologics’ upcoming fifth plant will be operational by April 2025, five months earlier than previously expected, the biotech company revealed at BIO International Convention on Monday 5.

How Cytiva is 'fuelling innovation' with its customer-centric approach

Back in May, Cytiva completed its integration with Pall Life Sciences, a move that CEO Emmanuel Ligner now describes as a “winning recipe” which has improved the company’s supply chain and fostered industry collaboration.

Veeva Business Consulting expands with new R&D services

Veeva has announced the expansion of its business consulting services to help life sciences organizations achieve “greater speed and efficiency” across the product development lifecycle.

Providence Therapeutics partners with University Health Network for mRNA development

Providence Therapeutics, a biopharmaceutical company developing mRNA vaccines and therapeutics, has announced its partnership with University Health Network (UHN).